Gemini Therapeutics, Inc. ($GMTX)
Filing Information
| Accession Number | 0001193125-26-003075 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 6, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
19,500
Total Value
$599,221.76
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common Stock | โ | Jan 2, 2026 | Exercise/Conversion | 6,500 | $13.50 | $87,750.00 | 44,293 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Jan 2, 2026 | Sale | 350 | $77.67 | $27,184.92 | 43,943 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Jan 2, 2026 | Sale | 4,993 | $78.62 | $392,569.13 | 38,950 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Jan 2, 2026 | Sale | 1,157 | $79.27 | $91,717.70 | 37,793 | Direct | โ | View Details | |
Chief Legal Officer | Stock Option (Right to Buy) | Derivative | Jan 2, 2026 | Exercise/Conversion | 6,500 | $0.00 | $0.00 | 22,270 | Direct | โ | View Details |